This report contains market size and forecasts of Non-Invasive Blood Glucose Monitoring Devices in global, including the following market information:
Global Non-Invasive Blood Glucose Monitoring Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Non-Invasive Blood Glucose Monitoring Devices Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Non-Invasive Blood Glucose Monitoring Devices companies in 2021 (%)
The global Non-Invasive Blood Glucose Monitoring Devices market was valued at 7 million in 2021 and is projected to reach US$ 19 million by 2028, at a CAGR of 15.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
MIR/NIR (Mid/Near Infrared Spectroscopy) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Non-Invasive Blood Glucose Monitoring Devices include Abbott, BD Medical, Medtronic, Sanofi, Roche Diagnostics, Animas Technologies, Bayer Healthcare, Cercacor and Pendragon Medical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Non-Invasive Blood Glucose Monitoring Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non-Invasive Blood Glucose Monitoring Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Non-Invasive Blood Glucose Monitoring Devices Market Segment Percentages, by Type, 2021 (%)
MIR/NIR (Mid/Near Infrared Spectroscopy)
Raman Spectroscopy
Occlusion Spectroscopy
Optical Coherence Tomography
Photoacoustic Spectroscopy
Electromagnetic
Fluorescence
Other
Global Non-Invasive Blood Glucose Monitoring Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Non-Invasive Blood Glucose Monitoring Devices Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Home Care Settings
Other
Global Non-Invasive Blood Glucose Monitoring Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Non-Invasive Blood Glucose Monitoring Devices Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Non-Invasive Blood Glucose Monitoring Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Non-Invasive Blood Glucose Monitoring Devices revenues share in global market, 2021 (%)
Key companies Non-Invasive Blood Glucose Monitoring Devices sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Non-Invasive Blood Glucose Monitoring Devices sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
BD Medical
Medtronic
Sanofi
Roche Diagnostics
Animas Technologies
Bayer Healthcare
Cercacor
Pendragon Medical
OrSense
Nova Biomedical
Dexcom
Terumo
Tosoh Bioscience